Concepedia

Daoping Zhou

DZ

Statistics

Publications

14

Citations

981

H-Index

14

Active since

1995

Affiliations

Nanjing Medical University(Current)

Wuxi People's Hospital

University of Massachusetts Boston

Anhui Provincial Hospital

Jiangnan University

Daoping Zhou is an author at Nanjing Medical University specializing in oncology, medicine, and molecular oncology.

Publications per year

1995–2022

14

Publications

14

RETRACTED: Downregulation of lncRNA GAS5 confers tamoxifen resistance by activating miR-222 in breast cancer

Juan Gu, Yueping Wang, Xuedong Wang et al. · Cancer Letters · 2018 · 143 citations

Medicine, Molecular Biology, Oncology +14

Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-β signaling pathway

Guang Shan, Juan Gu, Daoping Zhou et al. · Experimental & Molecular Medicine · 2020 · 124 citations · Full text

Medicine, Cancer Biology, Oncology +17

Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN

Guang Shan, Xike Zhou, Juan Gu et al. · Cellular Oncology · 2021 · 114 citations · Full text

Medicine, Cancer Biology, Oncology +17

Expression of multidrug resistance-associated protein (MRP) and multidrug resistance (MDR1) genes in acute myeloid leukemia.

Daoping Zhou, R Zittoun, J. P. Marie · PubMed · 1995 · 111 citations

Medicine, Oncology, Pharmacology +12

Homoharringtonine: an effective new natural product in cancer chemotherapy.

Daoping Zhou, R Zittoun, J. P. Marie · PubMed · 1995 · 97 citations

Medicine, Medicinal Chemistry, Oncology +6

1–5 of 14